PFAS contamination is rarely diffuse and mysterious. In most affected systems it traces to a definable source, and identifying which one matters — it determines how the plume will behave, whether concentrations will rise or fall, whether costs can be recovered from a responsible party, and what treatment will face.
This article covers the sources, how PFAS moves through the environment, who is exposed and how, and what the risks are. Treatment technologies are covered separately in our overview of PFAS removal technologies.
Each source produces a characteristic mixture. Foam sites carry large fractions of precursors that convert to regulated compounds over time, meaning concentrations can rise years after use stopped. Manufacturing sites often show distinctive replacement chemistries. Landfill leachate carries a broad mixture reflecting consumer products. Recognizing the pattern supports both source attribution and prediction of how contamination will develop.
The carbon-fluorine bond is among the strongest in organic chemistry, and it resists the biological and chemical processes that degrade most organic contaminants. Perfluorinated compounds do not meaningfully break down in the environment on human timescales. Polyfluorinated precursors do degrade — but into perfluorinated compounds, which then persist.
PFAS are generally soluble and mobile in groundwater, and short-chain compounds are more mobile than long-chain ones. A practical consequence is that plumes often separate: short-chain compounds travel furthest and arrive first, while long-chain compounds are retarded closer to the source. A well at the leading edge of a plume may show a very different profile from one near the source.
Long-chain PFAS bind more strongly to soil organic matter, so they are retained nearer the source while shorter chains leach. PFAS also accumulate at air-water interfaces, including in the unsaturated zone, which affects how they migrate downward.
Some PFAS — particularly volatile precursors such as fluorotelomer alcohols — travel through air and deposit at distance, which is how contamination appears well beyond any direct discharge. Ultrashort-chain compounds such as trifluoroacetic acid also form from atmospheric breakdown of fluorinated refrigerants.
Long-chain PFAS accumulate in organisms, and concentrations increase up food chains. This is why fish consumption advisories for PFAS have been issued for water bodies in many states, and why contamination of agricultural land raises concerns about produce, dairy, and meat.
Drinking water receives the most attention, but it is one of several routes, and its relative importance depends on circumstances:
PFAS are not absorbed significantly through skin during bathing or showering, which is why point-of-use treatment at the kitchen tap addresses most of the drinking water risk without whole-house treatment.
Research associates PFAS exposure with a range of effects. The strength of evidence varies by compound and endpoint, and is strongest for the long-studied compounds PFOA and PFOS:
PFAS persist in the human body for years, so exposure accumulates. Infants, young children, and pregnant women are generally considered more susceptible, which is reflected in how health-based values are derived.
Regulatory limits are measured in parts per trillion, which places heavy demands on sampling and analysis. PFAS are present in many field materials — fluoropolymer equipment above all — so contamination during sampling is a constant risk, and field blanks are essential. Standard methods also measure only a few dozen of the thousands of PFAS that exist, so a clean result for the regulated compounds does not mean PFAS are absent.
EPA finalized enforceable drinking water limits in April 2024: 4.0 parts per trillion for PFOA and PFOS, with limits for PFHxS, PFNA, HFPO-DA, and a hazard index for mixtures, and compliance required by 2029. In May 2026, EPA proposed retaining the PFOA and PFOS limits with an optional extension to 2031 and rescinding the others; as of September 2026 these remain proposals.
Separately, EPA designated PFOA and PFOS as CERCLA hazardous substances in 2024, bringing PFAS contamination within the Superfund liability framework — significant for sites with identifiable responsible parties.
State requirements vary considerably. Several states set drinking water standards before federal action, some regulate compounds beyond the federal list, and others restrict PFAS in products or in biosolids land application. State requirements are frequently the binding constraint.
Characterizing contamination properly shapes everything that follows. The PFAS profile determines which treatment technology suits, because short-chain compounds break through adsorptive media far sooner than long-chain ones. Source identification determines whether contamination is likely to worsen and whether costs may be recoverable. And exposure understanding determines what interim advice to give a community while a longer-term solution is built.
Where treatment is needed, the proven technologies are granular activated carbon, PFAS-selective anion exchange, and high-pressure membranes — set out for drinking water applications in our guide to drinking water PFAS removal systems and combined into working process configurations in our coverage of the PFAS treatment train. Where PFAS arrives at a wastewater plant, the constraints differ substantially, as discussed in our analysis of wastewater PFAS treatment.
One point deserves emphasis because it is widely misunderstood: conventional treatment — coagulation, filtration, chlorination — removes essentially no PFAS, and conventional advanced oxidation does not destroy it. A modern, well-run treatment plant without dedicated PFAS treatment provides no barrier.
PFAS contamination usually has a traceable origin: firefighting foam, fluorochemical manufacturing, industrial use, landfills, or land-applied biosolids. Understanding which applies tells you how the contamination will behave, what mixture of compounds to expect, and whether concentrations are likely to rise as precursors degrade.
That understanding is the foundation for everything else — treatment selection, exposure advice, cost recovery, and communication. Systems that invest in characterizing their contamination properly, including the compounds outside the regulated list, make better decisions than those that test only for what the rule requires and treat the result as the whole picture.